Moderna loses key patent challenge

被引：2

|

作者：

不详

机构：

来源：

NATURE BIOTECHNOLOGY | 2020年 / 38卷 / 09期

关键词：

D O I：

10.1038/s41587-020-0674-1

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：1009 / 1009

页数：1

相关论文

共 50 条

[41] What the Moderna–NIH COVID vaccine patent fight means for research
Heidi Ledford
[J]. Nature, 2021, 600 : 200 - 201
[42] Vancomycin research effort loses a key contributor
不详
[J]. SCIENTIST, 1996, 10 (12): : 8 - 8
[43] Los Alamos ‘loses’ key weapons data
Rex Dalton
[J]. Nature, 2000, 405 : 725 - 725
[44] BIOGEN LOSES PATENT CASE INVOLVING MS DRUG REBIF
Zweig, Steven J.
[J]. BIOTECHNOLOGY LAW REPORT, 2018, 37 (02) : 61 - 61
[45] Los Alamos 'loses' key weapons data
Dalton, R
[J]. NATURE, 2000, 405 (6788) : 725 - 725
[46] BMA loses challenge to new criteria for consultant status
不详
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1998, 317 (7172): : 1598 - 1598
[47] Man with advanced MND loses challenge for an assisted death
Dyer, Clare
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2017, 359 : j4631
[48] Charity loses fast-growing chicken challenge
Gray, Arabella
[J]. VETERINARY RECORD, 2023, 192 (11) : 427 - 427
[49] What the Moderna-NIH COVID vaccine patent fight means for research
Ledford, Heidi
[J]. NATURE, 2021, 600 (7888) : 200 - 201
[50] AstraZeneca loses Toprol-XL patent over double patenting
Harrison, Charlotte
[J]. NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (09) : 692 - 692

← 1 2 3 4 5 →